GGrantIndex
← Search

NEXT-GENERATION CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING FOLR1 FOR THE TREATMENT OF OVARIAN CANCER

$413,750FY2025Defense Health AgencyDOD

University Of Southern California, Los Angeles CA

Investigators

View source on USAspending →
NEXT-GENERATION CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING FOLR1 FOR THE TREATMENT OF OVARIAN CANCER · GrantIndex